Orthopaedic & Rheumatologic Institute Outcomes
Surgical Quality Improvement
Total Knee Arthroplasty Outcomes
Total Knee Arthroplasty ACS NSQIP Outcomes
January 1, 2024 – December 31, 2024
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall total knee arthroplasty ACS NSQIP performance benchmarked against 486 participating sites.
| Total Knee Arthroplasty (486 sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 214 | 2.80% | 3.96% |
| Ventilator > 48 Hours | 214 | 0.47% | 0.03% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 214 | 0.93% | 1.08% |
| Renal Failure | 214 | 1.40% | 0.26% |
| Urinary Tract Infection (UTI) | 214 | 0.47% | 0.66% |
| Surgical Site Infection (SSI) | 214 | 0.00% | 1.43% |
| Sepsis | 214 | 0.47% | 0.27% |
| C.diff Colitis | 214 | 0.00% | 0.04% |
| Unplanned Reoperation | 214 | 0.47% | 1.36% |
| Unplanned Readmission | 214 | 3.27% | 4.35% |
American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.
